Despite extensive correlative studies of HIV-infected persons and ex vivo studies of their peripheral blood immune cells, fundamental questions about HIV pathogenesis and immunity remain unanswered. Secondary and mucosa-associated lymphoid tissues are particularly important in HIV infection as primary sites of viral replication and CD4+ T cell depletion, and immune responses, but difficult to study in humans. To study host-pathogen interactions in tissue compartments, and effects of perturbations of immune responses, investigators have turned to animal models. Unfortunately, an ideal animal model of HIV infection has remained elusive. Although simian immunodeficiency virus (SIV) infection of rhesus macaques has provided many critically important insights into retroviral pathogenesis and immunity, there are differences inherent in macaque immune responses to SIV and human responses to HIV. The utility of the traditional mouse model for HIV infection has been limited by HIV's inability to productively infect mouse immune cells. To circumvent this, chimeric humanized mice with human immune cells and/or tissues have been generated. Building on earlier models, HU CFAR Core H has been able to make an improved humanized BLT (bone marrow-liver-thymus) mouse model widely available that allows CFAR members to model the development of humoral and cellular human immune responses to HIV, and mucosal transmission of HIV. Working with multiple HU CFAR investigators during the past funding period. Core H has demonstrated that BLT mice recapitulate an eclipse phase of HIV infection immediately following exposure of the vaginal mucosa to HIV challenge; generate functional human cellular and humoral immune responses to HIV; and support advanced in vivo imaging of HIV infection by multiphoton-intravital microscopy and bioluminescence imaging. In the coming funding period. Core H will provide access to BLT and other models of humanized mice as a newly named Humanized Mouse Core. Core H will generate these mice and perform experimental procedures including HIV infection with them for all requesting HU CFAR investigators. Additionally, Core H will continue to work on improving the humanized mouse models of HIV that they provide, to expand the areas of investigation that these models can support.
Specific aims of this Core include: 1. Generation of humanized BLT mice. 2. Generation of Hu-HSC mice and Hu-PBL mice. 3. Performance of experimental procedures on humanized mice. 4. Further improvement of humanized mouse models of HIV.

Public Health Relevance

Despite effective treatments, HIV/AIDS remains a leading cause of death and lost years of productive life worldwide. New interventions to prevent or treat HIV are therefore urgently needed, but their development will require better understanding of HIV transmission and pathogenesis, and anti-HIV immune responses. By providing an improved humanized mouse model of HIV infection. Core H will enable HU CFAR members to investigate HIV pathogenesis and transmission, and human anti-HIV immune responses, in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI060354-13
Application #
9111793
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
13
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
Hill, Alison L; Rosenbloom, Daniel I S; Nowak, Martin A et al. (2018) Insight into treatment of HIV infection from viral dynamics models. Immunol Rev 285:9-25
Milligan, Michael G; Bigger, Elizabeth; Abramson, Jeremy S et al. (2018) Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana. J Glob Oncol :1-11
O'Laughlin, Kelli N; He, Wei; Greenwald, Kelsy E et al. (2018) Feasibility and acceptability of home-based HIV testing among refugees: a pilot study in Nakivale refugee settlement in southwestern Uganda. BMC Infect Dis 18:332
Jiang, Wei; Luo, Zhenwu; Martin, Lisa et al. (2018) Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy. Curr HIV Res 16:143-150
Draz, Mohamed Shehata; Venkataramani, Manasa; Lakshminarayanan, Harini et al. (2018) Nanoparticle-enhanced electrical detection of Zika virus on paper microchips. Nanoscale 10:11841-11849
Muiru, Anthony N; Bibangambah, Prossy; Hemphill, Linda et al. (2018) Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda. J Acquir Immune Defic Syndr 78:458-464
Dale, Sannisha K; Pierre-Louis, Catherine; Bogart, Laura M et al. (2018) Still I rise: The need for self-validation and self-care in the midst of adversities faced by Black women with HIV. Cultur Divers Ethnic Minor Psychol 24:15-25
Blass, Eryn; Aid, Malika; Martinot, Amanda J et al. (2018) Adenovirus Vector Vaccination Impacts NK Cell Rheostat Function following Lymphocytic Choriomeningitis Virus Infection. J Virol 92:
Dale, Sannisha K; Safren, Steven A (2018) Striving Towards Empowerment and Medication Adherence (STEP-AD): A Tailored Cognitive Behavioral Treatment Approach for Black Women Living With HIV. Cogn Behav Pract 25:361-376
Addison, Daniel; Lawler, Patrick R; Emami, Hamed et al. (2018) Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer. J Stroke 20:71-79

Showing the most recent 10 out of 1030 publications